• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SK-N-SH神经母细胞瘤细胞对4-氟-3-碘苄胍和间碘苄胍的分解代谢

Catabolism of 4-fluoro-3-iodobenzylguanidine and meta-iodobenzylguanidine by SK-N-SH neuroblastoma cells.

作者信息

Vaidyanathan Ganesan, Affleck Donna J, Alston Kevin L, Welsh Philip, Zalutsky Michael R

机构信息

Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

Nucl Med Commun. 2004 Sep;25(9):947-55. doi: 10.1097/00006231-200409000-00013.

DOI:10.1097/00006231-200409000-00013
PMID:15319601
Abstract

BACKGROUND

A fluorine substituted derivative of meta-iodobenzylguanidine (MIBG), 4-fluoro-3-iodobenzylguanidine (FIBG), is retained in SK-N-SH human neuroblastoma cells in vitro to a higher degree than the MIBG.

METHOD

To investigate whether the higher retention of FIBG is due to differences in the catabolic degradation of the two tracers, in vitro paired-label studies were performed using SK-N-SH cells.

RESULTS

No detectable amount of benzyl amines, benzoic acids or hippuran derivatives, potential catabolites of these tracers, were seen in either case. Even after 48 h, the cell culture supernatants contained exclusively intact I-MIBG and I-FIBG. In contrast, in some cases, HPLC analysis of cell lysates indicated the presence of a very polar compound(s) as the predominant species with smaller quantities of intact tracers. The per cent total radioactivity in the lysate at each time point that was associated with intact I-FIBG was (average [range]) 25.4% [20.3-30.5], 22.5% [19.3-25.6], and 18.8% [14.3-23.3], at 0 h, 24 h and 48 h, respectively. The corresponding values for I-MIBG were 24.3% [21.0-27.5], 19.1% [11.7-26.5] and 17.4% [14.6-20.1]. No significant amount of activity was associated with high molecular weight species for either halobenzylguanidine, indicating that protein binding was not a major factor.

摘要

背景

间碘苄胍(MIBG)的一种氟取代衍生物,4-氟-3-碘苄胍(FIBG),在体外人SK-N-SH神经母细胞瘤细胞中的潴留程度高于MIBG。

方法

为研究FIBG较高的潴留率是否归因于这两种示踪剂分解代谢的差异,使用SK-N-SH细胞进行了体外配对标记研究。

结果

在两种情况下均未检测到这些示踪剂的潜在分解代谢产物苄胺、苯甲酸或马尿酸衍生物。即使在48小时后,细胞培养上清液中仅含有完整的I-MIBG和I-FIBG。相比之下,在某些情况下,细胞裂解物的高效液相色谱分析表明存在一种极性很强的化合物作为主要成分,而完整示踪剂的量较少。在0小时、24小时和48小时时,与完整I-FIBG相关的裂解物中总放射性百分比(平均值[范围])分别为25.4%[20.3-30.5]、22.5%[19.3-25.6]和18.8%[14.3-23.3]。I-MIBG的相应值分别为24.3%[21.0-27.5]、19.1%[11.7-26.5]和17.4%[14.6-20.1]。两种卤代苄胍与高分子量物质相关的活性均无显著差异,表明蛋白质结合不是主要因素。

相似文献

1
Catabolism of 4-fluoro-3-iodobenzylguanidine and meta-iodobenzylguanidine by SK-N-SH neuroblastoma cells.SK-N-SH神经母细胞瘤细胞对4-氟-3-碘苄胍和间碘苄胍的分解代谢
Nucl Med Commun. 2004 Sep;25(9):947-55. doi: 10.1097/00006231-200409000-00013.
2
No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.无载体添加碘-131-间碘苄胍:一种间碘苄胍类似物的评估
J Nucl Med. 1997 Feb;38(2):330-4.
3
A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cells.一种在人神经母细胞瘤细胞中具有延长滞留时间的4-甲基取代间碘苄胍类似物。
Eur J Nucl Med Mol Imaging. 2004 Oct;31(10):1362-70. doi: 10.1007/s00259-004-1596-8. Epub 2004 Jun 16.
4
3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.3-[211At]砹-4-氟苄基胍:一种可被神经母细胞瘤细胞长时间摄取的潜在治疗剂。
Br J Cancer. 1997;76(2):226-33. doi: 10.1038/bjc.1997.366.
5
Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG.4-[18F]氟丙氧基-3-碘苄胍([18F]FPOIBG)的合成与评价:一种新型的18F标记的间碘苄胍类似物。
Nucl Med Biol. 2015 Aug;42(8):673-84. doi: 10.1016/j.nucmedbio.2015.04.005. Epub 2015 Apr 20.
6
Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG.4-[氟-18]氟-3-碘苄胍作为间碘苄胍正电子发射类似物的验证
J Nucl Med. 1995 Apr;36(4):644-50.
7
Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: tissue distribution, metabolism and therapeutic efficacy.间碘苄胍对SK-N-SH人神经母细胞瘤异种移植瘤的靶向作用:组织分布、代谢及治疗效果。
Int J Cancer. 2000 Aug 1;87(3):412-22. doi: 10.1002/1097-0215(20000801)87:3<412::aid-ijc16>3.0.co;2-x.
8
(4-[18F]fluoro-3-iodobenzyl)guanidine, a potential MIBG analogue for positron emission tomography.(4-[18F]氟-3-碘苄基)胍,一种用于正电子发射断层扫描的潜在间碘苄胍类似物。
J Med Chem. 1994 Oct 14;37(21):3655-62. doi: 10.1021/jm00047a022.
9
Pharmacokinetics and efficacy of 131I-meta-iodobenzylguanidine in two neuroblastoma xenografts.131I-间碘苄胍在两种神经母细胞瘤异种移植模型中的药代动力学及疗效
Br J Radiol. 1994 Jun;67(798):573-8. doi: 10.1259/0007-1285-67-798-573.
10
Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells.间碘苄胍在人神经母细胞瘤SK-N-SH细胞中的主动摄取和囊泡外储存
Cancer Res. 1989 Jun 1;49(11):2941-4.

引用本文的文献

1
Recent advances in radiotracers targeting norepinephrine transporter: structural development and radiolabeling improvements.近年来靶向去甲肾上腺素转运体的放射性示踪剂的研究进展:结构发展和放射性标记的改进。
J Neural Transm (Vienna). 2020 Jun;127(6):851-873. doi: 10.1007/s00702-020-02180-4. Epub 2020 Apr 9.